Evidence map›Paper›PMID 25179737›Full record

ArticlePsychiatric services (Washington, D.C.)2014

Second-generation antipsychotic use among stimulant-using children, by organization of medicaid mental health.

Brendan Saloner, Meredith Matone, Amanda R Kreider, M Samer Budeir, Dorothy Miller, Yuan-Shung Huang, Ramesh Raghavan, Benjamin French, David Rubin

Abstract read
In one paragraph

Article in Psychiatric services (Washington, D.C.), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Brendan SalonerDr. Saloner is with the Department of Health Care Policy, Johns Hopkins University, Baltimore (e-mail: bsaloner@gmail.com ). Ms. Matone, Ms. Kreider, Mr. Budeir, Ms. Miller, and Dr. Rubin are with PolicyLab, Children's Hospital of Philadelphia, Philadelphia. Dr. Rubin is also with the Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia. Ms. Huang is with Division of General Pediatrics and Healthcare Analytics Unit, Children's Hospital of Philadelphia. Dr. Raghavan is with the George Warren Brown School of Social Work, Washington University in St. Louis, St. Louis, Missouri. Dr. French is with the Department of Biostatistics and Epidemiology, University of Pennsylvania, Philadelphia.
Meredith Matone
Amanda R Kreider
M Samer Budeir
Dorothy Miller
Yuan-Shung Huang
Ramesh Raghavan
Benjamin French
David Rubin

Funding

Reducing Disparities in Mental Health Expenditure Among Children in Child WelfareR01MH092312 · NIMH · WASHINGTON UNIVERSITY · PI RAGHAVAN, RAMESH · 2011 to 2013
$797k
STRENGTHENING MEDICAID-FUNDED MENTAL HEALTH COVERAGE FOR CHILDREN IN CHILD WELFARR01HS020269 · AHRQ · WASHINGTON UNIVERSITY · PI RAGHAVAN, RAMESH · 2011 to 2013
$634k
AHRQ HHS R01HS01855001A1AHRQ HHS R01 HS020269NIMH NIH HHS R01 MH092312
6 · The paper itself

Abstract

objectiveReducing overuse of second-generation antipsychotics among Medicaid-enrolled children is a national priority, yet little is known about how service organization affects use. This study compared differences in second-generation antipsychotic utilization among Medicaid-enrolled children across fee-for-service, integrated managed care, and managed behavioral health carve-out organizational structures.

methodsOrganizational structures of Medicaid programs in 82 diverse counties in 34 states were categorized and linked to child-level cross-sectional claims data from the Medicaid Analytic Extract covering fiscal years 2004, 2006, and 2008. To approximate the population at risk of antipsychotic treatment, the sample was restricted to stimulant-using children ages three to 18 (N=419,226). The sample was stratified by Medicaid eligibility group, and logistic regression models were estimated for probability of second-generation antipsychotic use. Models included indicators of county-level organizational structure as main predictors, with sequential adjustment for personal and county-level covariates.

resultsWith adjustment for person-level covariates, second-generation antipsychotic use was 31% higher among youths in foster care in fee-for-service counties than for youths in counties with carve-outs (odds ratio [OR]=1.69, 95% confidence interval [CI]=1.26-2.27). Foster care youths in integrated counties had the second highest adjusted odds (OR=1.31, CI=1.08-1.58). Similar patterns of use also were found for youths eligible for Supplemental Security Income but not for those eligible for Temporary Assistance for Needy Families. Differences persisted after adjustment for county-level characteristics.

conclusionsCarve-outs, versus other arrangements, were associated with lower second-generation antipsychotic use. Future research should explore carve-out features (for example, tighter management of inpatient or restricted access, as well as care coordination) contributing to lower second-generation antipsychotic use.

Indexed as

MedicaidMental HealthAdolescentAntipsychotic AgentsCentral Nervous System StimulantsChildChild, PreschoolEligibility DeterminationFee-for-Service PlansHumansInappropriate PrescribingMaleManaged Care ProgramsMental DisordersUnited StatesAntipsychotic AgentsCentral Nervous System Stimulants

Identifiers

PMID25179737
PMCPMC4757898

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.